Compare PAY & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAY | ACLX |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.2B |
| IPO Year | 2021 | 2022 |
| Metric | PAY | ACLX |
|---|---|---|
| Price | $30.05 | $64.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $37.43 | ★ $115.71 |
| AVG Volume (30 Days) | 661.4K | ★ 1.5M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.09 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $1,123,926,000.00 | $35,898,000.00 |
| Revenue This Year | $36.74 | N/A |
| Revenue Next Year | $21.73 | $302.49 |
| P/E Ratio | $64.47 | ★ N/A |
| Revenue Growth | ★ 44.34 | N/A |
| 52 Week Low | $22.65 | $47.86 |
| 52 Week High | $40.43 | $94.07 |
| Indicator | PAY | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 34.46 | 32.13 |
| Support Level | $29.58 | $68.64 |
| Resistance Level | $31.07 | $73.98 |
| Average True Range (ATR) | 1.25 | 4.47 |
| MACD | -0.60 | -0.47 |
| Stochastic Oscillator | 5.83 | 6.61 |
Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.